Vireo Growth (VREOF) Profit After Tax (2020 - 2026)
Vireo Growth's (VREOF) quarterly Profit After Tax came in at -$20.3 million in Q1 2026, down 212.31% year-on-year from $18.1 million in Q1 2025, and little changed quarter-over-quarter from -$20.4 million in Q4 2025.
Vireo Growth (VREOF) Profit After Tax (2020 - 2026) Analysis & Trends
Vireo Growth has disclosed Profit After Tax across 7 years of filings, most recently posting -$20.3 million for Q1 2026.
- Profit After Tax for Q1 2026 came in at -$20.3 million, down 212.31% year-over-year; the trailing twelve-month figure through Mar 2026 was -$81.9 million (down 194.66% YoY), and the FY2025 annual result was -$68.1 million, down 143.2% from the prior year.
- Profit After Tax came in at -$20.3 million for Q1 2026 at Vireo Growth, roughly flat from -$20.4 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of -$668411.0 in Q2 2024 to a low of -$26.3 million in Q3 2025.
- The 5-year median for Profit After Tax is -$8.4 million (2023), against an average of -$10.8 million.
- Across the five-year window, Profit After Tax soared 90.88% in 2024 and tumbled 2134.26% in 2025, its largest moves.
- Vireo Growth's Profit After Tax stood at -$13.3 million in 2022, then jumped by 65.5% to -$4.6 million in 2023, then plunged by 242.61% to -$15.7 million in 2024, then declined by 29.75% to -$20.4 million in 2025, then advanced by 0.35% to -$20.3 million in 2026.
- The last three Profit After Tax figures came in at -$20.3 million (Q1 2026), -$20.4 million (Q4 2025), and -$26.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 369.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -1.36 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 197.90 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 16.20 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -92.12 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 118.42 Mn |
| 10 | Vireo Growth | - | - | 59.30 Mn | -20.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.30 Mn |
| Dec 31, 2025 | -20.37 Mn |
| Sep 30, 2025 | -26.30 Mn |
| Jun 30, 2025 | -14.93 Mn |
| Mar 31, 2025 | -6.50 Mn |
| Dec 31, 2024 | -15.70 Mn |
| Sep 30, 2024 | -4.93 Mn |
| Jun 30, 2024 | -668,411.00 |
| Mar 31, 2024 | -6.71 Mn |
| Dec 31, 2023 | -4.58 Mn |
| Sep 30, 2023 | -5.23 Mn |
| Jun 30, 2023 | -7.33 Mn |
| Mar 31, 2023 | -8.41 Mn |
| Dec 31, 2022 | -13.28 Mn |
| Sep 30, 2022 | -8.42 Mn |
| Jun 30, 2022 | -6.18 Mn |
| Mar 31, 2022 | -14.57 Mn |
| Dec 31, 2021 | -12.93 Mn |
| Sep 30, 2021 | -6.87 Mn |
| Jun 30, 2021 | -7.01 Mn |